AFX-2

· Afexa Life Sciences Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AFX-2, covering 2012-01-25 to 2012-01-25. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1B- Open Label Dose-Ranging Study of Oral AFX-2 in Adults With Chronic Lymphocytic Leukemia [Phase 1]